nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—Promazine—Tamoxifen—pancreatic cancer	0.306	1	CrCrCtD
Prochlorperazine—CYP2D6—Tamoxifen—pancreatic cancer	0.0456	0.203	CbGbCtD
Prochlorperazine—CYP2D6—Erlotinib—pancreatic cancer	0.0387	0.173	CbGbCtD
Prochlorperazine—CYP3A4—Tamoxifen—pancreatic cancer	0.029	0.129	CbGbCtD
Prochlorperazine—CYP3A4—Erlotinib—pancreatic cancer	0.0246	0.11	CbGbCtD
Prochlorperazine—CYP3A4—Irinotecan—pancreatic cancer	0.0222	0.0993	CbGbCtD
Prochlorperazine—CYP2D6—Doxorubicin—pancreatic cancer	0.0191	0.0853	CbGbCtD
Prochlorperazine—CYP3A4—Docetaxel—pancreatic cancer	0.0163	0.0728	CbGbCtD
Prochlorperazine—CYP3A4—Sunitinib—pancreatic cancer	0.0162	0.0724	CbGbCtD
Prochlorperazine—CYP3A4—Doxorubicin—pancreatic cancer	0.0122	0.0543	CbGbCtD
Prochlorperazine—Oedema—Tamoxifen—pancreatic cancer	0.000895	0.00259	CcSEcCtD
Prochlorperazine—Infection—Tamoxifen—pancreatic cancer	0.000889	0.00257	CcSEcCtD
Prochlorperazine—Oedema—Erlotinib—pancreatic cancer	0.000886	0.00256	CcSEcCtD
Prochlorperazine—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000885	0.00256	CcSEcCtD
Prochlorperazine—Infection—Erlotinib—pancreatic cancer	0.00088	0.00254	CcSEcCtD
Prochlorperazine—Dyskinesia—Epirubicin—pancreatic cancer	0.000878	0.00254	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000876	0.00253	CcSEcCtD
Prochlorperazine—Amenorrhoea—Doxorubicin—pancreatic cancer	0.000869	0.00251	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.000869	0.00251	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000867	0.0025	CcSEcCtD
Prochlorperazine—Skin disorder—Erlotinib—pancreatic cancer	0.00086	0.00248	CcSEcCtD
Prochlorperazine—Angioedema—Sunitinib—pancreatic cancer	0.000858	0.00248	CcSEcCtD
Prochlorperazine—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000853	0.00246	CcSEcCtD
Prochlorperazine—Gait disturbance—Epirubicin—pancreatic cancer	0.000846	0.00244	CcSEcCtD
Prochlorperazine—Leukopenia—Sunitinib—pancreatic cancer	0.000841	0.00243	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Epirubicin—pancreatic cancer	0.000825	0.00238	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Epirubicin—pancreatic cancer	0.000825	0.00238	CcSEcCtD
Prochlorperazine—Cough—Sunitinib—pancreatic cancer	0.00082	0.00237	CcSEcCtD
Prochlorperazine—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000819	0.00236	CcSEcCtD
Prochlorperazine—Dermatitis contact—Epirubicin—pancreatic cancer	0.000816	0.00236	CcSEcCtD
Prochlorperazine—Convulsion—Sunitinib—pancreatic cancer	0.000814	0.00235	CcSEcCtD
Prochlorperazine—Dyskinesia—Doxorubicin—pancreatic cancer	0.000813	0.00235	CcSEcCtD
Prochlorperazine—Insomnia—Tamoxifen—pancreatic cancer	0.00081	0.00234	CcSEcCtD
Prochlorperazine—Insomnia—Erlotinib—pancreatic cancer	0.000801	0.00231	CcSEcCtD
Prochlorperazine—Dyspnoea—Tamoxifen—pancreatic cancer	0.000798	0.0023	CcSEcCtD
Prochlorperazine—Arrhythmia—Irinotecan—pancreatic cancer	0.000794	0.00229	CcSEcCtD
Prochlorperazine—Dyspnoea—Erlotinib—pancreatic cancer	0.00079	0.00228	CcSEcCtD
Prochlorperazine—Gait disturbance—Doxorubicin—pancreatic cancer	0.000782	0.00226	CcSEcCtD
Prochlorperazine—Dry mouth—Sunitinib—pancreatic cancer	0.000782	0.00226	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Epirubicin—pancreatic cancer	0.000775	0.00224	CcSEcCtD
Prochlorperazine—Arrhythmia—Gemcitabine—pancreatic cancer	0.000774	0.00223	CcSEcCtD
Prochlorperazine—Dysphagia—Docetaxel—pancreatic cancer	0.000768	0.00222	CcSEcCtD
Prochlorperazine—Oedema—Sunitinib—pancreatic cancer	0.000767	0.00221	CcSEcCtD
Prochlorperazine—Constipation—Tamoxifen—pancreatic cancer	0.000766	0.00221	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.000764	0.00221	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Doxorubicin—pancreatic cancer	0.000764	0.00221	CcSEcCtD
Prochlorperazine—Infection—Sunitinib—pancreatic cancer	0.000762	0.0022	CcSEcCtD
Prochlorperazine—Arrhythmia—Fluorouracil—pancreatic cancer	0.000761	0.0022	CcSEcCtD
Prochlorperazine—Constipation—Erlotinib—pancreatic cancer	0.000757	0.00219	CcSEcCtD
Prochlorperazine—Dermatitis contact—Doxorubicin—pancreatic cancer	0.000755	0.00218	CcSEcCtD
Prochlorperazine—Coma—Epirubicin—pancreatic cancer	0.000754	0.00218	CcSEcCtD
Prochlorperazine—Erythema—Gemcitabine—pancreatic cancer	0.000754	0.00218	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000751	0.00217	CcSEcCtD
Prochlorperazine—Skin disorder—Sunitinib—pancreatic cancer	0.000745	0.00215	CcSEcCtD
Prochlorperazine—Muscle spasms—Irinotecan—pancreatic cancer	0.000744	0.00215	CcSEcCtD
Prochlorperazine—Erythema—Fluorouracil—pancreatic cancer	0.000741	0.00214	CcSEcCtD
Prochlorperazine—Pancytopenia—Docetaxel—pancreatic cancer	0.000729	0.00211	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.000717	0.00207	CcSEcCtD
Prochlorperazine—Urticaria—Tamoxifen—pancreatic cancer	0.000711	0.00205	CcSEcCtD
Prochlorperazine—Body temperature increased—Erlotinib—pancreatic cancer	0.0007	0.00202	CcSEcCtD
Prochlorperazine—Weight increased—Docetaxel—pancreatic cancer	0.000699	0.00202	CcSEcCtD
Prochlorperazine—Vision blurred—Fluorouracil—pancreatic cancer	0.000698	0.00202	CcSEcCtD
Prochlorperazine—Coma—Doxorubicin—pancreatic cancer	0.000698	0.00202	CcSEcCtD
Prochlorperazine—Insomnia—Sunitinib—pancreatic cancer	0.000693	0.002	CcSEcCtD
Prochlorperazine—Leukopenia—Irinotecan—pancreatic cancer	0.000693	0.002	CcSEcCtD
Prochlorperazine—Dyspnoea—Sunitinib—pancreatic cancer	0.000684	0.00197	CcSEcCtD
Prochlorperazine—Photosensitivity—Epirubicin—pancreatic cancer	0.000682	0.00197	CcSEcCtD
Prochlorperazine—Cough—Irinotecan—pancreatic cancer	0.000675	0.00195	CcSEcCtD
Prochlorperazine—Leukopenia—Gemcitabine—pancreatic cancer	0.000675	0.00195	CcSEcCtD
Prochlorperazine—Jaundice—Docetaxel—pancreatic cancer	0.000667	0.00193	CcSEcCtD
Prochlorperazine—Eczema—Epirubicin—pancreatic cancer	0.000667	0.00193	CcSEcCtD
Prochlorperazine—Leukopenia—Fluorouracil—pancreatic cancer	0.000663	0.00192	CcSEcCtD
Prochlorperazine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00066	0.0019	CcSEcCtD
Prochlorperazine—Cough—Gemcitabine—pancreatic cancer	0.000658	0.0019	CcSEcCtD
Prochlorperazine—Constipation—Sunitinib—pancreatic cancer	0.000656	0.00189	CcSEcCtD
Prochlorperazine—Convulsion—Fluorouracil—pancreatic cancer	0.000642	0.00185	CcSEcCtD
Prochlorperazine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000639	0.00184	CcSEcCtD
Prochlorperazine—Increased appetite—Epirubicin—pancreatic cancer	0.000638	0.00184	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000635	0.00183	CcSEcCtD
Prochlorperazine—Pruritus—Tamoxifen—pancreatic cancer	0.000633	0.00183	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000632	0.00182	CcSEcCtD
Prochlorperazine—Oedema—Irinotecan—pancreatic cancer	0.000632	0.00182	CcSEcCtD
Prochlorperazine—Photosensitivity—Doxorubicin—pancreatic cancer	0.000631	0.00182	CcSEcCtD
Prochlorperazine—Infection—Irinotecan—pancreatic cancer	0.000627	0.00181	CcSEcCtD
Prochlorperazine—Pruritus—Erlotinib—pancreatic cancer	0.000627	0.00181	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000619	0.00179	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000618	0.00179	CcSEcCtD
Prochlorperazine—Eczema—Doxorubicin—pancreatic cancer	0.000617	0.00178	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000615	0.00178	CcSEcCtD
Prochlorperazine—Oedema—Gemcitabine—pancreatic cancer	0.000615	0.00178	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000614	0.00177	CcSEcCtD
Prochlorperazine—Infection—Gemcitabine—pancreatic cancer	0.000611	0.00176	CcSEcCtD
Prochlorperazine—Body temperature increased—Sunitinib—pancreatic cancer	0.000606	0.00175	CcSEcCtD
Prochlorperazine—Oedema peripheral—Docetaxel—pancreatic cancer	0.000605	0.00175	CcSEcCtD
Prochlorperazine—Oedema—Fluorouracil—pancreatic cancer	0.000605	0.00175	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000605	0.00175	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000602	0.00174	CcSEcCtD
Prochlorperazine—Infection—Fluorouracil—pancreatic cancer	0.000601	0.00174	CcSEcCtD
Prochlorperazine—Skin disorder—Gemcitabine—pancreatic cancer	0.000598	0.00173	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000592	0.00171	CcSEcCtD
Prochlorperazine—Dizziness—Tamoxifen—pancreatic cancer	0.000592	0.00171	CcSEcCtD
Prochlorperazine—Hypotension—Irinotecan—pancreatic cancer	0.00059	0.0017	CcSEcCtD
Prochlorperazine—Increased appetite—Doxorubicin—pancreatic cancer	0.00059	0.0017	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000588	0.0017	CcSEcCtD
Prochlorperazine—Dizziness—Erlotinib—pancreatic cancer	0.000586	0.00169	CcSEcCtD
Prochlorperazine—Erythema multiforme—Docetaxel—pancreatic cancer	0.000581	0.00168	CcSEcCtD
Prochlorperazine—Hypotension—Gemcitabine—pancreatic cancer	0.000575	0.00166	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000573	0.00165	CcSEcCtD
Prochlorperazine—Insomnia—Irinotecan—pancreatic cancer	0.000571	0.00165	CcSEcCtD
Prochlorperazine—Cardiac arrest—Epirubicin—pancreatic cancer	0.00057	0.00165	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000568	0.00164	CcSEcCtD
Prochlorperazine—Hypotension—Fluorouracil—pancreatic cancer	0.000565	0.00163	CcSEcCtD
Prochlorperazine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000565	0.00163	CcSEcCtD
Prochlorperazine—Rash—Tamoxifen—pancreatic cancer	0.000564	0.00163	CcSEcCtD
Prochlorperazine—Dermatitis—Tamoxifen—pancreatic cancer	0.000564	0.00163	CcSEcCtD
Prochlorperazine—Dyspnoea—Irinotecan—pancreatic cancer	0.000563	0.00163	CcSEcCtD
Prochlorperazine—Somnolence—Irinotecan—pancreatic cancer	0.000561	0.00162	CcSEcCtD
Prochlorperazine—Headache—Tamoxifen—pancreatic cancer	0.000561	0.00162	CcSEcCtD
Prochlorperazine—Rash—Erlotinib—pancreatic cancer	0.000558	0.00161	CcSEcCtD
Prochlorperazine—Dermatitis—Erlotinib—pancreatic cancer	0.000558	0.00161	CcSEcCtD
Prochlorperazine—Insomnia—Gemcitabine—pancreatic cancer	0.000556	0.00161	CcSEcCtD
Prochlorperazine—Headache—Erlotinib—pancreatic cancer	0.000555	0.0016	CcSEcCtD
Prochlorperazine—Arrhythmia—Docetaxel—pancreatic cancer	0.000549	0.00159	CcSEcCtD
Prochlorperazine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000548	0.00158	CcSEcCtD
Prochlorperazine—Insomnia—Fluorouracil—pancreatic cancer	0.000547	0.00158	CcSEcCtD
Prochlorperazine—Somnolence—Gemcitabine—pancreatic cancer	0.000547	0.00158	CcSEcCtD
Prochlorperazine—Pruritus—Sunitinib—pancreatic cancer	0.000542	0.00157	CcSEcCtD
Prochlorperazine—Constipation—Irinotecan—pancreatic cancer	0.00054	0.00156	CcSEcCtD
Prochlorperazine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000539	0.00156	CcSEcCtD
Prochlorperazine—Somnolence—Fluorouracil—pancreatic cancer	0.000538	0.00155	CcSEcCtD
Prochlorperazine—Erythema—Docetaxel—pancreatic cancer	0.000535	0.00154	CcSEcCtD
Prochlorperazine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000527	0.00152	CcSEcCtD
Prochlorperazine—Constipation—Gemcitabine—pancreatic cancer	0.000526	0.00152	CcSEcCtD
Prochlorperazine—Asthma—Epirubicin—pancreatic cancer	0.000518	0.0015	CcSEcCtD
Prochlorperazine—Influenza—Epirubicin—pancreatic cancer	0.000518	0.0015	CcSEcCtD
Prochlorperazine—Dysphagia—Epirubicin—pancreatic cancer	0.000518	0.0015	CcSEcCtD
Prochlorperazine—Muscle spasms—Docetaxel—pancreatic cancer	0.000514	0.00149	CcSEcCtD
Prochlorperazine—Eosinophilia—Epirubicin—pancreatic cancer	0.000513	0.00148	CcSEcCtD
Prochlorperazine—Dizziness—Sunitinib—pancreatic cancer	0.000507	0.00146	CcSEcCtD
Prochlorperazine—Body temperature increased—Irinotecan—pancreatic cancer	0.000499	0.00144	CcSEcCtD
Prochlorperazine—Pancytopenia—Epirubicin—pancreatic cancer	0.000492	0.00142	CcSEcCtD
Prochlorperazine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000486	0.0014	CcSEcCtD
Prochlorperazine—Rash—Sunitinib—pancreatic cancer	0.000483	0.0014	CcSEcCtD
Prochlorperazine—Dermatitis—Sunitinib—pancreatic cancer	0.000483	0.00139	CcSEcCtD
Prochlorperazine—Urticaria—Fluorouracil—pancreatic cancer	0.000481	0.00139	CcSEcCtD
Prochlorperazine—Headache—Sunitinib—pancreatic cancer	0.00048	0.00139	CcSEcCtD
Prochlorperazine—Asthma—Doxorubicin—pancreatic cancer	0.000479	0.00138	CcSEcCtD
Prochlorperazine—Influenza—Doxorubicin—pancreatic cancer	0.000479	0.00138	CcSEcCtD
Prochlorperazine—Dysphagia—Doxorubicin—pancreatic cancer	0.000479	0.00138	CcSEcCtD
Prochlorperazine—Leukopenia—Docetaxel—pancreatic cancer	0.000479	0.00138	CcSEcCtD
Prochlorperazine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000478	0.00138	CcSEcCtD
Prochlorperazine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000474	0.00137	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000473	0.00136	CcSEcCtD
Prochlorperazine—Weight increased—Epirubicin—pancreatic cancer	0.000471	0.00136	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000467	0.00135	CcSEcCtD
Prochlorperazine—Cough—Docetaxel—pancreatic cancer	0.000467	0.00135	CcSEcCtD
Prochlorperazine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000465	0.00134	CcSEcCtD
Prochlorperazine—Convulsion—Docetaxel—pancreatic cancer	0.000463	0.00134	CcSEcCtD
Prochlorperazine—Drowsiness—Epirubicin—pancreatic cancer	0.000462	0.00133	CcSEcCtD
Prochlorperazine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000455	0.00131	CcSEcCtD
Prochlorperazine—Jaundice—Epirubicin—pancreatic cancer	0.00045	0.0013	CcSEcCtD
Prochlorperazine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000446	0.00129	CcSEcCtD
Prochlorperazine—Dry mouth—Docetaxel—pancreatic cancer	0.000445	0.00129	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000437	0.00126	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000437	0.00126	CcSEcCtD
Prochlorperazine—Oedema—Docetaxel—pancreatic cancer	0.000437	0.00126	CcSEcCtD
Prochlorperazine—Weight increased—Doxorubicin—pancreatic cancer	0.000436	0.00126	CcSEcCtD
Prochlorperazine—Pruritus—Gemcitabine—pancreatic cancer	0.000435	0.00126	CcSEcCtD
Prochlorperazine—Infection—Docetaxel—pancreatic cancer	0.000434	0.00125	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000432	0.00125	CcSEcCtD
Prochlorperazine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000431	0.00124	CcSEcCtD
Prochlorperazine—Pruritus—Fluorouracil—pancreatic cancer	0.000428	0.00124	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000427	0.00123	CcSEcCtD
Prochlorperazine—Drowsiness—Doxorubicin—pancreatic cancer	0.000427	0.00123	CcSEcCtD
Prochlorperazine—Skin disorder—Docetaxel—pancreatic cancer	0.000424	0.00122	CcSEcCtD
Prochlorperazine—Dizziness—Irinotecan—pancreatic cancer	0.000418	0.00121	CcSEcCtD
Prochlorperazine—Jaundice—Doxorubicin—pancreatic cancer	0.000416	0.0012	CcSEcCtD
Prochlorperazine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000408	0.00118	CcSEcCtD
Prochlorperazine—Hypotension—Docetaxel—pancreatic cancer	0.000408	0.00118	CcSEcCtD
Prochlorperazine—Dizziness—Fluorouracil—pancreatic cancer	0.0004	0.00116	CcSEcCtD
Prochlorperazine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000399	0.00115	CcSEcCtD
Prochlorperazine—Rash—Irinotecan—pancreatic cancer	0.000398	0.00115	CcSEcCtD
Prochlorperazine—Dermatitis—Irinotecan—pancreatic cancer	0.000398	0.00115	CcSEcCtD
Prochlorperazine—Headache—Irinotecan—pancreatic cancer	0.000396	0.00114	CcSEcCtD
Prochlorperazine—Insomnia—Docetaxel—pancreatic cancer	0.000395	0.00114	CcSEcCtD
Prochlorperazine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000392	0.00113	CcSEcCtD
Prochlorperazine—Dyspnoea—Docetaxel—pancreatic cancer	0.000389	0.00112	CcSEcCtD
Prochlorperazine—Somnolence—Docetaxel—pancreatic cancer	0.000388	0.00112	CcSEcCtD
Prochlorperazine—Rash—Gemcitabine—pancreatic cancer	0.000388	0.00112	CcSEcCtD
Prochlorperazine—Dermatitis—Gemcitabine—pancreatic cancer	0.000388	0.00112	CcSEcCtD
Prochlorperazine—Headache—Gemcitabine—pancreatic cancer	0.000385	0.00111	CcSEcCtD
Prochlorperazine—Rash—Fluorouracil—pancreatic cancer	0.000381	0.0011	CcSEcCtD
Prochlorperazine—Dermatitis—Fluorouracil—pancreatic cancer	0.000381	0.0011	CcSEcCtD
Prochlorperazine—Headache—Fluorouracil—pancreatic cancer	0.000379	0.00109	CcSEcCtD
Prochlorperazine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000378	0.00109	CcSEcCtD
Prochlorperazine—Constipation—Docetaxel—pancreatic cancer	0.000373	0.00108	CcSEcCtD
Prochlorperazine—Arrhythmia—Epirubicin—pancreatic cancer	0.00037	0.00107	CcSEcCtD
Prochlorperazine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000363	0.00105	CcSEcCtD
Prochlorperazine—Erythema—Epirubicin—pancreatic cancer	0.000361	0.00104	CcSEcCtD
Prochlorperazine—Nervousness—Epirubicin—pancreatic cancer	0.00035	0.00101	CcSEcCtD
Prochlorperazine—Muscle spasms—Epirubicin—pancreatic cancer	0.000347	0.001	CcSEcCtD
Prochlorperazine—Body temperature increased—Docetaxel—pancreatic cancer	0.000345	0.000997	CcSEcCtD
Prochlorperazine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000343	0.000989	CcSEcCtD
Prochlorperazine—Vision blurred—Epirubicin—pancreatic cancer	0.00034	0.000982	CcSEcCtD
Prochlorperazine—Erythema—Doxorubicin—pancreatic cancer	0.000334	0.000964	CcSEcCtD
Prochlorperazine—Agitation—Epirubicin—pancreatic cancer	0.000332	0.000957	CcSEcCtD
Prochlorperazine—Nervousness—Doxorubicin—pancreatic cancer	0.000324	0.000936	CcSEcCtD
Prochlorperazine—Leukopenia—Epirubicin—pancreatic cancer	0.000323	0.000933	CcSEcCtD
Prochlorperazine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000322	0.000929	CcSEcCtD
Prochlorperazine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000321	0.000927	CcSEcCtD
Prochlorperazine—Cough—Epirubicin—pancreatic cancer	0.000315	0.000909	CcSEcCtD
Prochlorperazine—Vision blurred—Doxorubicin—pancreatic cancer	0.000315	0.000909	CcSEcCtD
Prochlorperazine—Convulsion—Epirubicin—pancreatic cancer	0.000313	0.000903	CcSEcCtD
Prochlorperazine—Pruritus—Docetaxel—pancreatic cancer	0.000309	0.000892	CcSEcCtD
Prochlorperazine—Agitation—Doxorubicin—pancreatic cancer	0.000307	0.000886	CcSEcCtD
Prochlorperazine—Dry mouth—Epirubicin—pancreatic cancer	0.0003	0.000868	CcSEcCtD
Prochlorperazine—Leukopenia—Doxorubicin—pancreatic cancer	0.000299	0.000863	CcSEcCtD
Prochlorperazine—Oedema—Epirubicin—pancreatic cancer	0.000294	0.00085	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000294	0.00085	CcSEcCtD
Prochlorperazine—Infection—Epirubicin—pancreatic cancer	0.000293	0.000845	CcSEcCtD
Prochlorperazine—Cough—Doxorubicin—pancreatic cancer	0.000291	0.000841	CcSEcCtD
Prochlorperazine—Convulsion—Doxorubicin—pancreatic cancer	0.000289	0.000835	CcSEcCtD
Prochlorperazine—Dizziness—Docetaxel—pancreatic cancer	0.000289	0.000834	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000288	0.000833	CcSEcCtD
Prochlorperazine—Skin disorder—Epirubicin—pancreatic cancer	0.000286	0.000826	CcSEcCtD
Prochlorperazine—Dry mouth—Doxorubicin—pancreatic cancer	0.000278	0.000803	CcSEcCtD
Prochlorperazine—Rash—Docetaxel—pancreatic cancer	0.000275	0.000795	CcSEcCtD
Prochlorperazine—Hypotension—Epirubicin—pancreatic cancer	0.000275	0.000795	CcSEcCtD
Prochlorperazine—Dermatitis—Docetaxel—pancreatic cancer	0.000275	0.000794	CcSEcCtD
Prochlorperazine—Headache—Docetaxel—pancreatic cancer	0.000274	0.00079	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000272	0.000787	CcSEcCtD
Prochlorperazine—Oedema—Doxorubicin—pancreatic cancer	0.000272	0.000787	CcSEcCtD
Prochlorperazine—Infection—Doxorubicin—pancreatic cancer	0.000271	0.000782	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000267	0.00077	CcSEcCtD
Prochlorperazine—Insomnia—Epirubicin—pancreatic cancer	0.000266	0.000769	CcSEcCtD
Prochlorperazine—Skin disorder—Doxorubicin—pancreatic cancer	0.000265	0.000764	CcSEcCtD
Prochlorperazine—Dyspnoea—Epirubicin—pancreatic cancer	0.000263	0.000758	CcSEcCtD
Prochlorperazine—Somnolence—Epirubicin—pancreatic cancer	0.000262	0.000756	CcSEcCtD
Prochlorperazine—Hypotension—Doxorubicin—pancreatic cancer	0.000255	0.000735	CcSEcCtD
Prochlorperazine—Constipation—Epirubicin—pancreatic cancer	0.000252	0.000727	CcSEcCtD
Prochlorperazine—Insomnia—Doxorubicin—pancreatic cancer	0.000246	0.000712	CcSEcCtD
Prochlorperazine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000243	0.000701	CcSEcCtD
Prochlorperazine—Somnolence—Doxorubicin—pancreatic cancer	0.000242	0.000699	CcSEcCtD
Prochlorperazine—Urticaria—Epirubicin—pancreatic cancer	0.000234	0.000676	CcSEcCtD
Prochlorperazine—Constipation—Doxorubicin—pancreatic cancer	0.000233	0.000673	CcSEcCtD
Prochlorperazine—Body temperature increased—Epirubicin—pancreatic cancer	0.000233	0.000672	CcSEcCtD
Prochlorperazine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000217	0.000627	CcSEcCtD
Prochlorperazine—Urticaria—Doxorubicin—pancreatic cancer	0.000216	0.000625	CcSEcCtD
Prochlorperazine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000215	0.000622	CcSEcCtD
Prochlorperazine—Pruritus—Epirubicin—pancreatic cancer	0.000208	0.000602	CcSEcCtD
Prochlorperazine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000201	0.00058	CcSEcCtD
Prochlorperazine—Dizziness—Epirubicin—pancreatic cancer	0.000195	0.000562	CcSEcCtD
Prochlorperazine—Pruritus—Doxorubicin—pancreatic cancer	0.000193	0.000557	CcSEcCtD
Prochlorperazine—Rash—Epirubicin—pancreatic cancer	0.000186	0.000536	CcSEcCtD
Prochlorperazine—Dermatitis—Epirubicin—pancreatic cancer	0.000185	0.000536	CcSEcCtD
Prochlorperazine—Headache—Epirubicin—pancreatic cancer	0.000184	0.000533	CcSEcCtD
Prochlorperazine—Dizziness—Doxorubicin—pancreatic cancer	0.00018	0.00052	CcSEcCtD
Prochlorperazine—Rash—Doxorubicin—pancreatic cancer	0.000172	0.000496	CcSEcCtD
Prochlorperazine—Dermatitis—Doxorubicin—pancreatic cancer	0.000172	0.000496	CcSEcCtD
Prochlorperazine—Headache—Doxorubicin—pancreatic cancer	0.000171	0.000493	CcSEcCtD
Prochlorperazine—DRD2—Signaling Pathways—AGTR1—pancreatic cancer	3.53e-05	0.000285	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—STK11—pancreatic cancer	3.48e-05	0.000281	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.48e-05	0.000281	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	3.48e-05	0.000281	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AGTR1—pancreatic cancer	3.47e-05	0.00028	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.46e-05	0.000279	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SMAD4—pancreatic cancer	3.46e-05	0.000279	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—CXCL8—pancreatic cancer	3.42e-05	0.000276	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—STK11—pancreatic cancer	3.42e-05	0.000276	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	3.41e-05	0.000276	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TERT—pancreatic cancer	3.41e-05	0.000275	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HES1—pancreatic cancer	3.37e-05	0.000273	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—STK11—pancreatic cancer	3.36e-05	0.000272	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PIK3CD—pancreatic cancer	3.27e-05	0.000264	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HIF1A—pancreatic cancer	3.26e-05	0.000263	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TSC2—pancreatic cancer	3.25e-05	0.000263	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PIK3CB—pancreatic cancer	3.23e-05	0.000261	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PIK3CD—pancreatic cancer	3.21e-05	0.000259	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—APOE—pancreatic cancer	3.18e-05	0.000257	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	3.16e-05	0.000255	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.14e-05	0.000254	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—KDR—pancreatic cancer	3.12e-05	0.000252	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—CXCL8—pancreatic cancer	3.11e-05	0.000251	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.08e-05	0.000249	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SMAD4—pancreatic cancer	3.05e-05	0.000246	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.03e-05	0.000245	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.02e-05	0.000244	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—CXCL8—pancreatic cancer	3.02e-05	0.000244	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SMAD4—pancreatic cancer	2.99e-05	0.000242	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HES1—pancreatic cancer	2.98e-05	0.000241	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NFKBIA—pancreatic cancer	2.97e-05	0.00024	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.96e-05	0.000239	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TERT—pancreatic cancer	2.96e-05	0.000239	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	2.95e-05	0.000238	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NOTCH1—pancreatic cancer	2.94e-05	0.000237	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HES1—pancreatic cancer	2.92e-05	0.000236	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	2.92e-05	0.000236	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HES1—pancreatic cancer	2.88e-05	0.000232	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CG—pancreatic cancer	2.87e-05	0.000232	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—NRAS—pancreatic cancer	2.87e-05	0.000232	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PIK3CB—pancreatic cancer	2.85e-05	0.00023	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EGF—pancreatic cancer	2.84e-05	0.000229	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HIF1A—pancreatic cancer	2.83e-05	0.000228	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TSC2—pancreatic cancer	2.82e-05	0.000228	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.8e-05	0.000226	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—APOE—pancreatic cancer	2.76e-05	0.000223	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	2.76e-05	0.000223	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CXCL8—pancreatic cancer	2.74e-05	0.000221	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—KDR—pancreatic cancer	2.7e-05	0.000218	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CD44—pancreatic cancer	2.69e-05	0.000218	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CXCL8—pancreatic cancer	2.69e-05	0.000217	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	2.65e-05	0.000214	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—EGFR—pancreatic cancer	2.62e-05	0.000211	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TERT—pancreatic cancer	2.61e-05	0.000211	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GCG—pancreatic cancer	2.58e-05	0.000209	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NFKBIA—pancreatic cancer	2.57e-05	0.000208	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TERT—pancreatic cancer	2.56e-05	0.000207	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NOTCH1—pancreatic cancer	2.55e-05	0.000206	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CD—pancreatic cancer	2.53e-05	0.000204	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TERT—pancreatic cancer	2.52e-05	0.000204	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.5e-05	0.000202	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HIF1A—pancreatic cancer	2.5e-05	0.000202	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CG—pancreatic cancer	2.49e-05	0.000201	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—NRAS—pancreatic cancer	2.49e-05	0.000201	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TSC2—pancreatic cancer	2.49e-05	0.000201	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—KRAS—pancreatic cancer	2.47e-05	0.0002	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EGF—pancreatic cancer	2.46e-05	0.000199	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HIF1A—pancreatic cancer	2.45e-05	0.000198	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TSC2—pancreatic cancer	2.44e-05	0.000197	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.44e-05	0.000197	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—APOE—pancreatic cancer	2.44e-05	0.000197	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—STK11—pancreatic cancer	2.43e-05	0.000196	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	2.41e-05	0.000195	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	2.4e-05	0.000194	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.4e-05	0.000194	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—APOE—pancreatic cancer	2.39e-05	0.000193	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KDR—pancreatic cancer	2.39e-05	0.000193	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—APOE—pancreatic cancer	2.35e-05	0.00019	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KDR—pancreatic cancer	2.34e-05	0.000189	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KDR—pancreatic cancer	2.31e-05	0.000186	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.28e-05	0.000184	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—PIK3CA—pancreatic cancer	2.27e-05	0.000184	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	2.27e-05	0.000183	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—EGFR—pancreatic cancer	2.27e-05	0.000183	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	2.25e-05	0.000182	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	2.23e-05	0.00018	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	2.21e-05	0.000178	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CB—pancreatic cancer	2.2e-05	0.000178	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	2.2e-05	0.000178	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	2.2e-05	0.000178	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	2.19e-05	0.000177	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CD—pancreatic cancer	2.19e-05	0.000177	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGF—pancreatic cancer	2.17e-05	0.000176	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	2.17e-05	0.000175	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.17e-05	0.000175	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	2.16e-05	0.000174	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	2.16e-05	0.000174	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—KRAS—pancreatic cancer	2.14e-05	0.000173	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGF—pancreatic cancer	2.13e-05	0.000172	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	2.12e-05	0.000172	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	2.12e-05	0.000172	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CXCL8—pancreatic cancer	2.12e-05	0.000171	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—HRAS—pancreatic cancer	2.1e-05	0.00017	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGF—pancreatic cancer	2.1e-05	0.00017	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.09e-05	0.000169	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—AKT1—pancreatic cancer	2.04e-05	0.000165	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CASP3—pancreatic cancer	2.02e-05	0.000164	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	2e-05	0.000162	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CCND1—pancreatic cancer	1.97e-05	0.000159	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PIK3CA—pancreatic cancer	1.97e-05	0.000159	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	1.97e-05	0.000159	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CTNNB1—pancreatic cancer	1.95e-05	0.000158	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	1.94e-05	0.000156	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	1.93e-05	0.000156	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.91e-05	0.000155	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MMP9—pancreatic cancer	1.91e-05	0.000155	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CB—pancreatic cancer	1.91e-05	0.000154	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PTEN—pancreatic cancer	1.9e-05	0.000154	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	1.9e-05	0.000153	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	1.89e-05	0.000153	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.88e-05	0.000152	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	1.87e-05	0.000151	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	1.86e-05	0.00015	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—AKT1—pancreatic cancer	1.86e-05	0.00015	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.85e-05	0.000149	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CXCL8—pancreatic cancer	1.83e-05	0.000148	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	1.83e-05	0.000148	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HRAS—pancreatic cancer	1.82e-05	0.000147	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—AKT1—pancreatic cancer	1.77e-05	0.000143	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SRC—pancreatic cancer	1.76e-05	0.000143	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CD44—pancreatic cancer	1.76e-05	0.000142	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CASP3—pancreatic cancer	1.76e-05	0.000142	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.74e-05	0.00014	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—VEGFA—pancreatic cancer	1.72e-05	0.000139	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CCND1—pancreatic cancer	1.71e-05	0.000138	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.71e-05	0.000138	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—STAT3—pancreatic cancer	1.7e-05	0.000137	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—APOE—pancreatic cancer	1.7e-05	0.000137	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NRAS—pancreatic cancer	1.7e-05	0.000137	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CTNNB1—pancreatic cancer	1.69e-05	0.000137	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GCG—pancreatic cancer	1.69e-05	0.000136	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	1.68e-05	0.000136	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.68e-05	0.000136	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MMP9—pancreatic cancer	1.66e-05	0.000134	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	1.65e-05	0.000134	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	1.65e-05	0.000133	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	1.63e-05	0.000131	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	1.62e-05	0.000131	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	1.61e-05	0.00013	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	1.61e-05	0.00013	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	1.59e-05	0.000128	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—STK11—pancreatic cancer	1.59e-05	0.000128	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MYC—pancreatic cancer	1.58e-05	0.000128	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	1.58e-05	0.000128	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TGFB1—pancreatic cancer	1.58e-05	0.000127	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	1.56e-05	0.000126	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	1.56e-05	0.000126	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	1.55e-05	0.000126	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	1.55e-05	0.000125	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EGFR—pancreatic cancer	1.55e-05	0.000125	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	1.54e-05	0.000124	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.53e-05	0.000124	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SRC—pancreatic cancer	1.53e-05	0.000124	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	1.52e-05	0.000123	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	1.51e-05	0.000122	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	1.51e-05	0.000122	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	1.5e-05	0.000121	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	1.49e-05	0.000121	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	1.49e-05	0.00012	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	1.48e-05	0.00012	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.48e-05	0.00012	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	1.48e-05	0.000119	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	1.47e-05	0.000119	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	1.47e-05	0.000118	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	1.46e-05	0.000118	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—KRAS—pancreatic cancer	1.46e-05	0.000118	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	1.46e-05	0.000118	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	1.46e-05	0.000118	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	1.44e-05	0.000117	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	1.44e-05	0.000116	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	1.43e-05	0.000115	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	1.42e-05	0.000115	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	1.41e-05	0.000114	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	1.41e-05	0.000114	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	1.39e-05	0.000113	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	1.37e-05	0.000111	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	1.37e-05	0.000111	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	1.37e-05	0.00011	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.37e-05	0.00011	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SRC—pancreatic cancer	1.35e-05	0.000109	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.35e-05	0.000109	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	1.34e-05	0.000108	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	1.34e-05	0.000108	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SRC—pancreatic cancer	1.33e-05	0.000107	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	1.31e-05	0.000106	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	1.3e-05	0.000105	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	1.3e-05	0.000105	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	1.3e-05	0.000105	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TP53—pancreatic cancer	1.3e-05	0.000105	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	1.29e-05	0.000104	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	1.28e-05	0.000103	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	1.28e-05	0.000103	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	1.27e-05	0.000103	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	1.27e-05	0.000102	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	1.26e-05	0.000102	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	1.25e-05	0.000101	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HRAS—pancreatic cancer	1.24e-05	0.0001	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MYC—pancreatic cancer	1.21e-05	9.77e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	1.21e-05	9.75e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MYC—pancreatic cancer	1.19e-05	9.59e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	1.18e-05	9.57e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	1.18e-05	9.56e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.18e-05	9.49e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	1.17e-05	9.44e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	1.17e-05	9.42e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.16e-05	9.41e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	1.16e-05	9.4e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	1.16e-05	9.38e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	1.14e-05	9.23e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	1.13e-05	9.09e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	1.12e-05	9.03e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APOE—pancreatic cancer	1.11e-05	8.98e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	1.1e-05	8.87e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AKT1—pancreatic cancer	1.1e-05	8.86e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	1.08e-05	8.72e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	1.08e-05	8.7e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	1.03e-05	8.3e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.02e-05	8.2e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	1.01e-05	8.15e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1e-05	8.1e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TP53—pancreatic cancer	9.93e-06	8.03e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	9.92e-06	8.01e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TP53—pancreatic cancer	9.75e-06	7.88e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPARG—pancreatic cancer	9.68e-06	7.82e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	9.6e-06	7.75e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	9.51e-06	7.68e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	9.5e-06	7.68e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	9.33e-06	7.54e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	9.18e-06	7.41e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	8.82e-06	7.12e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	8.39e-06	6.78e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	8.24e-06	6.65e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	8.11e-06	6.55e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	7.68e-06	6.21e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	7.61e-06	6.15e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	7.16e-06	5.79e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTEN—pancreatic cancer	6.64e-06	5.36e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AKT1—pancreatic cancer	5.85e-06	4.73e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	4.68e-06	3.78e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AKT1—pancreatic cancer	3.83e-06	3.09e-05	CbGpPWpGaD
